Lataa...
EGF/EGFR upregulates and cooperates with Netrin-4 to protect glioblastoma cells from DNA damage-induced senescence
BACKGROUND: Glioblastoma multiforme (GBM) is the most malignant central nervous system tumor. Alkylating agent, temozolomide (TMZ), is currently the first-line chemotherapeutic agent for GBM. However, the sensitivity of GBM cells to TMZ is affected by many factors. And, several clinic trials, includ...
Tallennettuna:
Julkaisussa: | BMC Cancer |
---|---|
Päätekijät: | , , , , , , , , , , |
Aineistotyyppi: | Artigo |
Kieli: | Inglês |
Julkaistu: |
BioMed Central
2018
|
Aiheet: | |
Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6280426/ https://ncbi.nlm.nih.gov/pubmed/30514230 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-018-5056-4 |
Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|